𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil

✍ Scribed by Fred J. Ansfield; Guillermo Ramirez; Hugh L. Davis Jr.; George W. Wirtanen; Robert O. Johnson; George T. Bryan; Felipe B. Manalo; Ernest C. Borden; Thomas E. Davis; Muhammad Esmaili

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
369 KB
Volume
36
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Intrahepatic arterial infusion with 5-fl
Intrahepatic arterial infusion with 5-fluorouracil
✍ Fred J. Ansfield; Guillermo Ramirez; Joseph L. Skibba; George T. Bryan; Hugh L. πŸ“‚ Article πŸ“… 1971 πŸ› John Wiley and Sons 🌐 English βš– 427 KB

Since 1964, 200 patients were treated with intra-arterial 5-FU infusion. Of them, 127 failed with intravenously injected 5-FU, and 27 were unsuitable for such treatment as their involvement was so far advanced as to have jaundice d u e to extensive parenchymal involvement. In all b u t 12 patients,

Disposition of 5-fluorouracil during chr
Disposition of 5-fluorouracil during chronic hepatic arterial infusion to patients with carcinoma in the liver and effect on circulating platelets
✍ Daniel S. Sitar; John R. Ruedy; Douglas H. Shaw Jr.; Andrew W. Maksymiuk; Michae πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 383 KB πŸ‘ 1 views

## Abstract 5‐Fluorouracil was administered by continuous hepatic intra‐arterial infusion to eight patients with the diagnosis of cancer of the gastrointestinal tract and hepatic metastases. Its elimination characteristics were investigated to see if they correlated with therapeutic effect or reduc

Results of pharmacokinetic modulating ch
Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases
✍ Masato Kusunoki; Hidenori Yanagi; Masafumi Noda; Reigetsu Yoshikawa; Takehira Ya πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## BACKGROUND. Pharmacokinetic modulating chemotherapy (PMC) is a new therapeutic concept in combination with continuous 5-fluorouracil (5-FU) infusion and UFT. UFT enhanced plasma 5-FU concentration and antitumor effects during 5-FU infusion. The authors report on their experiences with arterial

Evaluation of low dose continuous infusi
Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study
✍ Julie A. Kish; Michael Wolf; E. David Crawford; Joseph T. Leimert; Anton Buesche πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 289 KB πŸ‘ 2 views

Background. The response rate of metastatic renal cell cancer to cytotoxic therapy over the last 10 years has been 5.6%. Low dose continuous 5-fluorouracil(5-FU) has demonstrated efficacy in other cytotoxic refractory tumors, such as pancreas, colorectal, and recurrent breast. The Southwest Oncology